NCT07690917招募中不适用
Quality Improvement Study of a New Generation of Whole Body PET Scanners
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 90
- 试验地点
- 7
- 主要终点
- image quality
研究概览
简要总结
The researchers are doing this study to test the capabilities of a new total-body PET scanner called the Biograph Vision Quadra. The researchers want to learn whether this scanner can produce better PET/CT images and provide more useful imaging information than standard PET/CT scanners.
详细描述
This protocol is a quality improvement protocol intended to explore and capitalize on the advanced performance characteristics of a new total body PET scanner; the Biograph Vision Quadra manufactured by Siemens Healthineers.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Eligibility Criteria for objective #1:
- •Patients with histologically-confirmed non-small cell lung carcinoma (NSCLC) with a single or multiple lung nodules.
- •Patients who are undergoing a planned PET-CT scan at main campus of MSK.
- •Patients must be ≥ 18 years old
- •Eligibility Criteria for objective #2:
- •Patients with disease within the chest, abdomen or pelvis, who could benefit from visualizing the pharmacokinetics of radiotracer uptake within all disease sites simultaneously.
- •Patients with metastatic prostate or head and neck cancer.
- •Patients with prostate cancer who are undergoing a 68Ga-PSMA or 18F-FDG scan at the main campus of MSK.
- •Patients with head and neck cancer who are undergoing a 18F-FDG scan at the main campus of MSK
- •Patients must be ≥ 18 years old
- •Eligibility Criteria for objective #3:
- •Patients with histologically-confirmed cancer from all three groups (lung cancer, head and neck cancer, prostate cancer).
- •Patients who are undergoing an 68Ga-PSMA or 18F-FDG or an [18F]-fluormisonidazole PET-CT scan at the main campus of MSK.
- •Patients willing to return to the MITS clinc for late imaging session between 2 to 6 hours after the PET radiotracer injection. (In current practice, FDG is imaged between 1 and 1.5 hours post injection, and FMISO is imaged between 2.5 and 3 hours post injection)
- •Patients must be ≥ 18 years old
排除标准
- •Patients who suffer from claustrophobia.
- •Women who are pregnant or breast-feeding.
- •Patients < 18 years of age
结局指标
主要结局
image quality
时间窗: 3 years
Detection of any new/additional lesions on the delayed scan will be recorded using standard clinical interpretation.
次要结局
未报告次要终点
研究者
研究点 (7)
Loading locations...
相似试验
Enrolling By Invitation
不适用
Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.NeuroblastomaPituitary AdenomaDementiaEpilepsyNCT07595666prof. dr. Koen Van Laere1,600
进行中（未招募）
不适用
EQUIP - Evaluation of Quality of Imaging on a Next-generation Total Body Pet Scan in Comparison to Conventional PETCancerNCT07263815Peter MacCallum Cancer Centre, Australia25
招募中
2 期
[68Ga]Ga-FAPI PET/CT for response evaluation during immune checkpoint inhibitor therapy in malignant melanoma2023-509549-11-00Rigshospitalet20
尚未招募
不适用
HELP Study - Towards High Throughput and Efficient Long-axial PET With Oral [18F]FDGMultiple CancersMultiple Indications CancerFeasibility StudiesNCT07295171British Columbia Cancer Agency27
招募中
2 期
BEFAST Study, [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in CancerNCT07629609Barbara Malene Fischer90